Silexion Therapeutics Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Silexion Therapeutics Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2023 to Q3 2024.
  • Silexion Therapeutics Corp Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $0.000.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $0 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $140K Jun 30, 2024 10-Q 2024-08-29
Q4 2023 $198K Dec 31, 2023 10-Q 2024-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.